Xie X - Search Results

1

CT23 knockdown attenuating malignant behaviors of hepatocellular carcinoma cell is associated with upregulation of metallothionein 1.

Ning W, Huang M, Wu S, Wang H, Yao J, Ge Y, Tang Y, Sun K, Xie X, Hu Q. Ning W, et al. Among authors: xie x. Cell Biol Int. 2021 Jun;45(6):1231-1245. doi: 10.1002/cbin.11567. Epub 2021 Feb 19. Cell Biol Int. 2021. PMID: 33559934

2

Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.

Zhou SF, Mo FR, Bin YH, Hou GQ, Xie XX, Luo GR. Zhou SF, et al. Clin Biochem. 2011 Mar;44(4):331-6. doi: 10.1016/j.clinbiochem.2010.10.008. Epub 2010 Nov 1. Clin Biochem. 2011. PMID: 21047503

3

Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.

Cen YH, Guo WW, Luo B, Lin YD, Zhang QM, Zhou SF, Luo GR, Xiao SW, Xie XX. Cen YH, et al. Cell Biol Int. 2012 Oct 1;36(10):917-22. doi: 10.1042/CBI20120037. Cell Biol Int. 2012. PMID: 22651134

4

Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cells.

Li JP, Cao NX, Jiang RT, He SJ, Huang TM, Wu B, Chen DF, Ma P, Chen L, Zhou SF, Xie XX, Luo GR. Li JP, et al. Asian Pac J Cancer Prev. 2014;15(6):2753-8. doi: 10.7314/apjcp.2014.15.6.2753. Asian Pac J Cancer Prev. 2014. PMID: 24761896 Free article.

5

OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.

Hu Q, Fu J, Luo B, Huang M, Guo W, Lin Y, Xie X, Xiao S. Hu Q, et al. Among authors: xie x. Oncol Rep. 2015 Apr;33(4):1965-75. doi: 10.3892/or.2015.3792. Epub 2015 Feb 10. Oncol Rep. 2015. PMID: 25673160

6

Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.

Fu J, Luo B, Guo WW, Zhang QM, Shi L, Hu QP, Chen F, Xiao SW, Xie XX. Fu J, et al. Int J Clin Exp Pathol. 2015 Jul 1;8(7):7786-97. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339343 Free PMC article.

7

Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.

Liu C, Luo B, Xie XX, Liao XS, Fu J, Ge YY, Li XS, Guo GS, Shen N, Xiao SW, Zhang QM. Liu C, et al. Curr Med Sci. 2018 Feb;38(1):19-25. doi: 10.1007/s11596-018-1842-0. Epub 2018 Mar 15. Curr Med Sci. 2018. PMID: 30074147

8

Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.

Luo B, Yun X, Li J, Fan R, Guo WW, Liu C, Lin YD, Ge YY, Zeng X, Bi SQ, Nong WX, Zhang QM, Xie XX. Luo B, et al. Among authors: xie xx. Curr Med Sci. 2020 Aug;40(4):719-728. doi: 10.1007/s11596-020-2241-x. Epub 2020 Aug 29. Curr Med Sci. 2020. PMID: 32862383

9

Expression profile of ACTL8, CTCFL, OIP5 and XAGE3 in glioma and their prognostic significance: a retrospective clinical study.

Li X, Ning L, Zhang Q, Ge Y, Liu C, Bi S, Zeng X, Nong W, Wu S, Guo G, Xiao S, Luo B, Xie X. Li X, et al. Among authors: xie x. Am J Transl Res. 2020 Dec 15;12(12):7782-7796. eCollection 2020. Am J Transl Res. 2020. PMID: 33437360 Free PMC article.

10

Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.

Liu C, Ge YY, Xie XX, Luo B, Shen N, Liao XS, Bi SQ, Xu T, Xiao SW, Zhang QM. Liu C, et al. Curr Med Sci. 2021 Apr;41(2):356-367. doi: 10.1007/s11596-021-2355-9. Epub 2021 Apr 20. Curr Med Sci. 2021. PMID: 33877554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,715 results

Search Page

Filters